Epidemiology, ventilation management and outcomes of COVID–19 ARDS patients versus patients with ARDS due to pneumonia in the Pre–COVID era
Fleur–Stefanie L. I. M. van der Ven(Rode Kruis Ziekenhuis), Frederique Paulus(Amsterdam University Medical Centers), Marcus J. Schultz(University of St.Gallen), Luigi Pisani(Ospedale Generale Regionale Francesco Miulli), Antonio Artigas(Instituto de Salud Carlos III), Ignacio Martín‐Loeches(St. James's Hospital), Juliana Carvalho Ferreira(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Siebe G. Blok, Ary Serpa Neto(The University of Melbourne), Tài Pham(University of California Davis Medical Center), Michela Botta(Amsterdam University Medical Centers), Eddy Fan(University Health Network), Ana Motos(Hospital Clínic de Barcelona), Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), John G. Laffey(University Hospital Galway), Elisa Estenssoro(National University of General San Martín), Luciano C. P. Azevedo(Hospital Israelita Albert Einstein), David M. P. van Meenen(Amsterdam University Medical Centers), Giacomo Bellani(University of Trento), Óscar Peñuelas(Instituto de Salud Carlos III), Antoni Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Cited by 15
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
|Intensive Care Medicine|2012|1.5k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k